The analyst writes that reimbursement for Cologuard Plus will now be calculated based on two components: three times the fee for methylation analysis of Septin-9 ($192 x 3) and the fee for a FIT ...

Until Cologuard launched 10 years ago, really your choices were colonoscopy or a fecal immunochemical test. Colonospy has its obvious advantages but also obvious disadvantages and the fit test is ...

The established screening tools were colonoscopy, a fecal immunochemical test (FIT), and a multitarget stool DNA test (MT-sDNA, Exact Sciences Cologuard). The four emerging screening methods were ...

The finalized CLFS pricing of $592 is based on a crosswalk to three markers and a Fecal Immunochemical Test (FIT), which is higher ... same level as the original Cologuard. Management at Exact ...

And you get a 3-year quality credit with Cologuard versus the FIT test, which is not a very accurate test, you only get 1 year of credit. So the payers are coming to us and now the large health ...

The updated fee schedule crosswalks Cologuard Plus to three times the contracted rate for Epi proColon, plus one time the rate for FIT, totaling a new contracted rate of $591.92. This adjustment ...

Related: The One Thing an OB/GYN Is Begging Women Over 50 to Stop Doing in 2025 The average age of a cervical cancer ...

Learn more about whether BioMarin Pharmaceutical Inc. or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

times three plus a FIT test ($15) to arrive at the final $592 price. Brennan noted that Septin 9 is a blood-based colorectal cancer screening test based on methylation in the SEPT9 gene. Cologuard ...

The updated fee schedule crosswalks Cologuard Plus to three times the contracted rate for Epi proColon, plus one time the rate for FIT, totaling a new contracted rate of $591.92. This adjustment is a ...